Vetter, a leading global contract development and manufacturing organization (CDMO), has announced its plans to move and expand its Development Services site from Skokie, Illinois, to Des Plaines, further investing in its US footprint.

Simultaneously, the company plans additional major investment in its commercial business in the state of Saarland, located in the Southwest of Germany bordering France and Luxembourg, to complement its growth and capacity expansions in Ravensburg and Langenargen which are currently underway.

This adds more capacity for future customers around the globe as the injectable industry is witnessing a rise in outsourcing development, manufacturing, assembly and packaging needs to CDMOs.

A few years ago, Vetter made a strategic investment by acquiring the Des Plaines site, demonstrating progressive thinking in business development. The recent decision by the Advisory Board will elevate Vetter Development Services to a new level, driven by growing customer needs at the current Skokie site, as well as at the company’s clinical manufacturing site in Rankweil, Austria.

This development plan involves a construction project at the Des Plaines site and the relocation and expansion of Vetter Development Services US from the Illinois Science and Technology Park over the next years. New buildings for clinical manufacturing and related services will be constructed. The move will effectively double the capacity of Vetter Development Services in the US and provide ample space for future expansion opportunities.

On the other hand, Saarland government plans to develop a technology park on the site in Saarlouis. Vetter has already started planning the phased development of a 125 acre site. The planned investment amounts to a value of several hundred million Euro. Pharmaceutical production at the site is expected to start by 2030 and Vetter is planning to create up to 2,000 new local jobs in the years to come.